The World Health Organization (WHO) has announced its prioritization of clinical trials for treatments and vaccines targeting Bundibugyo Ebola Virus Disease (BVD). Currently, there are no licensed therapeutics or vaccines specifically approved for the prevention or treatment of this disease. However, the WHO has identified several candidate products that show promise and will be evaluated in upcoming clinical trials to assess their efficacy and safety. This initiative aims to enhance the response to potential outbreaks of BVD.
Related Articles
Don't miss out on breaking stories and in-depth articles.